The Week In... Pharma (06-10/05)

The outgoing president of the ABPI says UK pharma is negotiating ‘choppy seas’ during Brexit, the new head of the ABPI is announced, IG.com take a look at top 10 healthcare stocks, and England opens new NHS ‘front door’ to health innovators. Read more -

The UK has far lower import costs in percentage terms than the US and China, analysis by accountancy firm UHY has shown, with Britain paying 0.5 per cent in duties on its imports in the 2017-18 financial year.